Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1950 1
1951 1
1952 4
1953 9
1954 4
1955 2
1956 5
1957 2
1959 1
1960 2
1961 2
1962 12
1963 13
1964 7
1965 5
1966 7
1967 10
1968 3
1969 8
1970 5
1971 4
1972 8
1973 6
1974 3
1975 8
1976 7
1977 13
1978 14
1979 15
1980 21
1981 27
1982 15
1983 20
1984 14
1985 19
1986 34
1987 17
1988 19
1989 14
1990 17
1991 25
1992 26
1993 26
1994 17
1995 12
1996 15
1997 23
1998 17
1999 31
2000 19
2001 19
2002 23
2003 35
2004 27
2005 25
2006 18
2007 19
2008 37
2009 43
2010 51
2011 36
2012 34
2013 50
2014 35
2015 46
2016 43
2017 45
2018 66
2019 51
2020 70
2021 81
2022 65
2023 79
2024 84
2025 57

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,621 results

Results by year

Filters applied: . Clear all
Page 1
What is vertigo?
Salvinelli F, Firrisi L, Casale M, Trivelli M, D'Ascanio L, Lamanna F, Greco F, Costantino S. Salvinelli F, et al. Among authors: greco f. Clin Ter. 2003 Sep-Oct;154(5):341-8. Clin Ter. 2003. PMID: 14994924 Review.
[PORTAL HYPERTENSION].
CHIANDUSSI L, GRECO F. CHIANDUSSI L, et al. Among authors: greco f. Omnia Med Ther. 1963 Jan-Jun;41:1-81. Omnia Med Ther. 1963. PMID: 14076801 Review. Italian. No abstract available.
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Among authors: greco f. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry.
Coletti A, Greco FA, Dolciami D, Camaioni E, Sardella R, Pallotta MT, Volpi C, Orabona C, Grohmann U, Macchiarulo A. Coletti A, et al. Among authors: greco fa. Medchemcomm. 2017 May 16;8(7):1378-1392. doi: 10.1039/c7md00109f. eCollection 2017 Jul 1. Medchemcomm. 2017. PMID: 30108849 Free PMC article. Review.
Chronic oral etoposide.
Greco FA, Johnson DH, Hainsworth JD. Greco FA, et al. Cancer. 1991 Jan 1;67(1 Suppl):303-9. doi: 10.1002/1097-0142(19910101)67:1+<303::aid-cncr2820671316>3.0.co;2-4. Cancer. 1991. PMID: 1984832 Review.
Introduction: unknown primary cancer.
Greco FA, Hainsworth JD. Greco FA, et al. Semin Oncol. 2009 Feb;36(1):6-7. doi: 10.1053/j.seminoncol.2008.10.007. Semin Oncol. 2009. PMID: 19179184 No abstract available.
Tumors of unknown origin.
Greco FA, Hainsworth JD. Greco FA, et al. CA Cancer J Clin. 1992 Mar-Apr;42(2):96-115. doi: 10.3322/canjclin.42.2.96. CA Cancer J Clin. 1992. PMID: 1540854 Free article. Review.
1,621 results